These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 206349)

  • 21. Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.
    Menezes J; Leibold W; Klein G; Clements G
    Biomedicine; 1975 Jul; 22(4):276-84. PubMed ID: 179629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
    Gregory CD; Rowe M; Rickinson AB
    J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen.
    Ernberg I; Kallin B; Dillner J; Falk K; Ehlin-Henriksson B; Hammarskjöld ML; Klein G
    Int J Cancer; 1986 Nov; 38(5):729-37. PubMed ID: 3021635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment of Epstein-Barr virus (EBV)-associated nuclear antigen (EBNA)-positive nasopharyngeal carcinoma hybrid cell line (NPC-KT).
    Takimoto T; Kamide M; Umeda R
    Arch Otorhinolaryngol; 1984; 239(1):87-92. PubMed ID: 6318711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus gene expression in nasopharyngeal carcinoma.
    Young LS; Dawson CW; Clark D; Rupani H; Busson P; Tursz T; Johnson A; Rickinson AB
    J Gen Virol; 1988 May; 69 ( Pt 5)():1051-65. PubMed ID: 2836550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nasopharyngeal carcinoma in Japan--clinical evaluation of EBV serology and EBV-associated nuclear antigens test.
    Takimoto T; Furukawa M; Morishita K; Umeda R; Hatano M
    Auris Nasus Larynx; 1982; 9(3):151-63. PubMed ID: 6301414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of Epstein-Barr virus-determined nuclear antigen (EBNA) by chromatography on fixed cell nuclei.
    Hirsch I; Suchánková A; Závadová H; Vonka V
    Int J Cancer; 1978 Nov; 22(5):535-41. PubMed ID: 82540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
    Ernberg I; Falk K; Minarovits J; Busson P; Tursz T; Masucci MG; Klein G
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An immunofluorescence technique with counterstain on fixed cells for the detection of antibodies to human herpesviruses; antibody patterns in patients with Hodgkin's disease and nasopharyngeal carcinoma.
    Hilgers F; Hilgers J
    Intervirology; 1976; 7(6):309-27. PubMed ID: 67099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigen-inducing ability of herpesvirus papio in human and baboon lymphoma lines, compared to Epstein-Barr virus.
    Klein G; Falk L; Falk K
    Intervirology; 1978; 10(3):153-64. PubMed ID: 210135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Titers of Epstein-Barr virus-related antibodies in nasopharyngeal carcinoma in Japan.
    Tamada A; Makimoto K; Yamabe H; Imai J; Hinuma Y; Oyagi A; Araki T
    Cancer; 1984 Feb; 53(3):430-40. PubMed ID: 6318948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Epstein-Barr virus determined nuclear antigen is composed of at least three different antigens.
    Dillner J; Kallin B; Ehlin-Henriksson B; Rymo L; Henle W; Henle G; Klein G
    Int J Cancer; 1986 Feb; 37(2):195-200. PubMed ID: 2417963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.
    Fåhraeus R; Fu HL; Ernberg I; Finke J; Rowe M; Klein G; Falk K; Nilsson E; Yadav M; Busson P
    Int J Cancer; 1988 Sep; 42(3):329-38. PubMed ID: 2843473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification and characterization of the Epstein-Barr virus nuclear antigen 2 using monoclonal antipeptide antibodies.
    Dillner J; Wendel-Hansen V; Kjellström G; Kallin B; Rosén A
    Int J Cancer; 1988 Nov; 42(5):721-7. PubMed ID: 2846447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
    Wang F; Gregory CD; Rowe M; Rickinson AB; Wang D; Birkenbach M; Kikutani H; Kishimoto T; Kieff E
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3452-6. PubMed ID: 3033649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary EBV infection of human umbilical cord lymphocytes and EBV genome-negative lymphoblastoid cell lines (BJAB and Ramos).
    Takimoto T; Sato H; Ogura H
    Auris Nasus Larynx; 1986; 13(3):199-205. PubMed ID: 3036055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics.
    Magrath IT; Pizzo PA; Whang-Peng J; Douglass EC; Alabaster O; Gerber P; Freeman CB; Novikovs L
    J Natl Cancer Inst; 1980 Mar; 64(3):465-76. PubMed ID: 6243721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus-specific leukocyte migration inhibition reaction with tumor biopsy extracts: correlation with the presence of viral DNA.
    Szigeti R; Saemundsen AK; Synnerholm AC; Henle G; Henle W; Klein G
    Cancer Res; 1983 May; 43(5):2273-6. PubMed ID: 6299543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Burkitt's lymphoma-Epstein-Barr virus association in western Algeria. Clinical, cytological and serological aspects apropos of 34 pediatric cases].
    Meziane F; Aguercif M; Chevallier A; Lavoue MF; Boukli H; Mehadji M; Boughermouh M
    Pediatrie; 1985 Mar; 40(2):87-98. PubMed ID: 3001633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease-related differences in antibody patterns against EBV-encoded nuclear antigens EBNA 1, EBNA 2 and EBNA 6.
    Lennette ET; Rymo L; Yadav M; Masucci G; Merk K; Timar L; Klein G
    Eur J Cancer; 1993; 29A(11):1584-9. PubMed ID: 8217366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.